Update on Emerging Treatment Options for Primary Biliary Cholangitis.

Hepat Med · 2020 · PMC7259454 · PMID 32547264

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

There was a trend towards improved serum biomarkers with the lower 30 mg dose of cilofexor that did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.